MEDICINAL CHEMISTRY STRATEGY MEETING EAST COAST 2025

Proventa's recent survey of Medicinal Chemistry leaders identifies Al/ML, Hit-to-Lead Optimization, and Design & Synthesis as key investment frontiers. Industry challenges such as data integration, informatics scalability, and constrained budgets continue to test innovation velocity. At the core of investment rationale are pipeline expansion, next-generation drug discovery, and capability building to navigate a rapidly digitizing R&D environment. Recognizing these dynamics is critical to shaping competitive medicinal chemistry strategies in an Al-augmented discovery era.